Skip to main content
Premium Trial:

Request an Annual Quote

Ambion: Aug 21, 2008

Premium
Ambion, a unit of Applied Biosystems, has recently introduced a new Anti-miR microRNA inhibitor positive control for hsa-let-7c.
 
According to the company, the validated positive control can be monitored in human or mouse cells by qRT-PCR using a TaqMan gene expression assay to HGMA2.
 
Ambion has also released sets of its Silencer Select siRNAs targeting the human druggable genome in sets grouped by gene target class. The siRNAs are available in a ready-to-ship 0.25 nanomolar format or in larger customer quantities.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.